104 related articles for article (PubMed ID: 22568098)
1. [Application of novel clinicopathological biomarkers].
Chano T
Rinsho Byori; 2012 Feb; 60(2):167-73. PubMed ID: 22568098
[TBL] [Abstract][Full Text] [Related]
2. RECQL1 and WRN proteins are potential therapeutic targets in head and neck squamous cell carcinoma.
Arai A; Chano T; Futami K; Furuichi Y; Ikebuchi K; Inui T; Tameno H; Ochi Y; Shimada T; Hisa Y; Okabe H
Cancer Res; 2011 Jul; 71(13):4598-607. PubMed ID: 21571861
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of RB1-inducible coiled-coil 1 in salivary gland cancers.
Tameno H; Chano T; Ikebuchi K; Ochi Y; Arai A; Kishimoto M; Shimada T; Hisa Y; Okabe H
Head Neck; 2012 May; 34(5):674-80. PubMed ID: 21717524
[TBL] [Abstract][Full Text] [Related]
4. RECQL1 and WRN DNA repair helicases: potential therapeutic targets and proliferative markers against cancers.
Futami K; Furuichi Y
Front Genet; 2014; 5():441. PubMed ID: 25620975
[TBL] [Abstract][Full Text] [Related]
5. DNA methyltransferase-3 like protein expression in various histological types of testicular germ cell tumor.
Matsuoka T; Kawai K; Ando S; Sugita S; Kandori S; Kojima T; Miyazaki J; Nishiyama H
Jpn J Clin Oncol; 2016 May; 46(5):475-81. PubMed ID: 26917601
[TBL] [Abstract][Full Text] [Related]
6. RecQL1 DNA repair helicase: A potential tumor marker and therapeutic target against hepatocellular carcinoma.
Futami K; Ogasawara S; Goto H; Yano H; Furuichi Y
Int J Mol Med; 2010 Apr; 25(4):537-45. PubMed ID: 20198302
[TBL] [Abstract][Full Text] [Related]
7. DNMT3L is a novel marker and is essential for the growth of human embryonal carcinoma.
Minami K; Chano T; Kawakami T; Ushida H; Kushima R; Okabe H; Okada Y; Okamoto K
Clin Cancer Res; 2010 May; 16(10):2751-9. PubMed ID: 20460473
[TBL] [Abstract][Full Text] [Related]
8. Expression of LC3B and FIP200/Atg17 in brain metastases of breast cancer.
Hashemi-Sadraei N; Müller-Greven GM; Abdul-Karim FW; Ulasov I; Downs-Kelly E; Burgett ME; Lauko A; Qadan MA; Weil RJ; Ahluwalia MS; Du L; Prayson RA; Chao ST; Budd TG; Barnholtz-Sloan J; Nowacki AS; Keri RA; Gladson CL
J Neurooncol; 2018 Nov; 140(2):237-248. PubMed ID: 30094720
[TBL] [Abstract][Full Text] [Related]
9. Testicular Cancer Biomarkers: A Role for Precision Medicine in Testicular Cancer.
Leão R; Ahmad AE; Hamilton RJ
Clin Genitourin Cancer; 2019 Feb; 17(1):e176-e183. PubMed ID: 30497810
[TBL] [Abstract][Full Text] [Related]
10. OCT4 staining in testicular tumors: a sensitive and specific marker for seminoma and embryonal carcinoma.
Jones TD; Ulbright TM; Eble JN; Baldridge LA; Cheng L
Am J Surg Pathol; 2004 Jul; 28(7):935-40. PubMed ID: 15223965
[TBL] [Abstract][Full Text] [Related]
11. Human RecQL4 helicase plays multifaceted roles in the genomic stability of normal and cancer cells.
Mo D; Zhao Y; Balajee AS
Cancer Lett; 2018 Jan; 413():1-10. PubMed ID: 29080750
[TBL] [Abstract][Full Text] [Related]
12. An up-date on newly discovered immunohistochemical biomarkers for the diagnosis of human testicular germ cell tumors.
Chieffi P; Chieffi S
Histol Histopathol; 2014 Aug; 29(8):999-1006. PubMed ID: 24627150
[TBL] [Abstract][Full Text] [Related]
13. RB1CC1 activates the promoter and expression of RB1 in human cancer.
Ikebuchi K; Chano T; Ochi Y; Tameno H; Shimada T; Hisa Y; Okabe H
Int J Cancer; 2009 Aug; 125(4):861-7. PubMed ID: 19437535
[TBL] [Abstract][Full Text] [Related]
14. Applications of molecular diagnostics for personalized treatment of head and neck cancer: state of the art.
Mes SW; Leemans CR; Brakenhoff RH
Expert Rev Mol Diagn; 2016; 16(2):205-21. PubMed ID: 26620464
[TBL] [Abstract][Full Text] [Related]
15. Cytokeratin 7, inhibin, and p63 in testicular germ cell tumor: superior markers of choriocarcinoma compared to β-human chorionic gonadotropin.
Wegman SJ; Parwani AV; Zynger DL
Hum Pathol; 2019 Feb; 84():254-261. PubMed ID: 30359635
[TBL] [Abstract][Full Text] [Related]
16. Current Clinical Applications of Testicular Cancer Biomarkers.
Mir MC; Pavan N; Gonzalgo ML
Urol Clin North Am; 2016 Feb; 43(1):119-25. PubMed ID: 26614034
[TBL] [Abstract][Full Text] [Related]
17. MiR-20a and miR-20b negatively regulate autophagy by targeting RB1CC1/FIP200 in breast cancer cells.
Li S; Qiang Q; Shan H; Shi M; Gan G; Ma F; Chen B
Life Sci; 2016 Feb; 147():143-52. PubMed ID: 26829385
[TBL] [Abstract][Full Text] [Related]
18. Gross cystic disease fluid protein-15 as a marker for breast cancer: immunohistochemical analysis of 690 human neoplasms and comparison with alpha-lactalbumin.
Wick MR; Lillemoe TJ; Copland GT; Swanson PE; Manivel JC; Kiang DT
Hum Pathol; 1989 Mar; 20(3):281-7. PubMed ID: 2542151
[TBL] [Abstract][Full Text] [Related]
19. Camptothecin targets WRN protein: mechanism and relevance in clinical breast cancer.
Shamanna RA; Lu H; Croteau DL; Arora A; Agarwal D; Ball G; Aleskandarany MA; Ellis IO; Pommier Y; Madhusudan S; Bohr VA
Oncotarget; 2016 Mar; 7(12):13269-84. PubMed ID: 26959889
[TBL] [Abstract][Full Text] [Related]
20. Preparation of mouse monoclonal antibody for RB1CC1 and its clinical application.
Hama Y; Chano T; Inui T; Matsumoto K; Okabe H
PLoS One; 2012; 7(3):e32052. PubMed ID: 22396748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
